Fellows

fellows

Peter Hartog, Helmholz Zentrum München, Germany and AstraZeneca AB, Sweden

Emma Svensson, Johannes Kepler Universität Linz, Austria and AstraZeneca AB, Sweden

Paula Torren PeraireHelmholz Zentrum München, Germany and Janssen Pharmaceutica NV, Belgium

Varvara Voinarovska, Helmholz Zentrum München, Germany, AstraZeneca AB, Sweden and  Enamine Limited Liability Company, Ukraine

Julian Cremer, Universitat Pompeu Fabra, Spain and Bayer Aktiengesellschaft, Germany

Son Hà, TU Dortmund, Germany/Johannes Gutenberg-Universität Mainz and Janssen Pharmaceutica NV, Belgium

Alan Kai HassenUniversiteit Leiden, Netherlands and Bayer Aktiengesellschaft, Germany

Ana Sánchez Fernández, Johannes Kepler Universität Linz, Austria and Janssen Pharmaceutica NV, Belgium

Yasmine Nahal, AstraZeneca AB, Sweden and Aalto University, Finland

Rosa Friesacher, Katholieke Universiteit Leuven, Belgium and AstraZeneca AB, Sweden

Vincenzo Palmacci, Bayer Aktiengesellschaft, Germany and University of Vienna, Austria

Mikhail Andronov, Scuola Universitaria Professionale della Svizzera Italiana, Switzerland and Bayer Aktiengesellschaft, Germany

Alessio Fallani, Université du Luxembourg, Luxembourg and Janssen Pharmaceutica NV, Belgium

Muhammad Arslan Masood, Aalto University, Finland and Janssen Pharmaceutica NV, Belgium

Mariia Radaeva, Vancouver Prostate Center, University of British Columbia, Canada